[Is there an age limit for cadaveric kidney donors currently?].
OBJECTIVE
The insufficient number of kidney transplants has gradually raised the age limit to the cadaver kidney donor. The use of grafts harvested from older donors has been debated due to the existing structural and functional changes that might influence renal function and long-term graft survival. The foregoing aspects are discussed herein.


METHODS
The anatomical, histological and functional changes in the kidney associated with ageing are analyzed. The clinical experience with renal grafts from older donors before and after cyclosporine became available are reviewed. The ethical issues on whether grafts from very old donors should be used and who should receive these grafts are discussed.


RESULTS
The use of grafts from donors over 60 years old had no significant short and medium term differences in comparison with younger donors in terms of graft survival, although a higher incidence of acute tubular necrosis and poor renal function have been observed. There are no conclusive studies on the long-term effects on graft survival when kidneys from donors aged over 65 are utilized. In our experience, the results achieved with grafts from donors over 70 has been unsatisfactory. The guidelines utilized in the selection of grafts derived from older donors are presented.


CONCLUSIONS
Grafts from donors aged 60 to 70 may be utilized in renal transplantation following precise selection criteria. Graft survival has been satisfactory, although a higher incidence of acute tubular necrosis and higher creatinine levels have been observed. We do not advocate the use of grafts from donors over 70, except in very exceptional cases. Long-term multicenter studies on grafts from very old donors and trials using alternative immunosuppressor modalities that might permit optimal use of these grafts are warranted.
Cofán Pujol
F
F
Unidad de Transplante Renal, Universidad de Barcelona, España.
Oppenheimer Salinas
F
F
Talbot-Wright
R
R
Carretero González
P
P
D000367:Age Factors; D002102:Cadaver; D003524:Cyclosporins / Q000008:administration & dosage; D006801:Humans; D016030:Kidney Transplantation; D014019:Tissue Donors
D003524:Cyclosporins